SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-064061
Filing Date
2017-10-26
Accepted
2017-10-26 17:11:54
Documents
7
Period of Report
2017-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-19042_98k.htm 8-K 31838
2 EX-1.1 a17-19042_9ex1d1.htm EX-1.1 234689
3 EX-5.1 a17-19042_9ex5d1.htm EX-5.1 14305
4 EX-99.1 a17-19042_9ex99d1.htm EX-99.1 11180
5 GRAPHIC g190429mmi001.jpg GRAPHIC 3108
6 GRAPHIC g190429kii001.gif GRAPHIC 1798
7 GRAPHIC g190429kii002.gif GRAPHIC 4548
  Complete submission text file 0001104659-17-064061.txt   306705
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 171157037
SIC: 2836 Biological Products, (No Diagnostic Substances)